DE69626680D1 - Kondensierte isoindolone als proteinkinase c inhibitoren - Google Patents

Kondensierte isoindolone als proteinkinase c inhibitoren

Info

Publication number
DE69626680D1
DE69626680D1 DE69626680T DE69626680T DE69626680D1 DE 69626680 D1 DE69626680 D1 DE 69626680D1 DE 69626680 T DE69626680 T DE 69626680T DE 69626680 T DE69626680 T DE 69626680T DE 69626680 D1 DE69626680 D1 DE 69626680D1
Authority
DE
Germany
Prior art keywords
inhibitors
protein kinase
isoindolones
fused
condensed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626680T
Other languages
English (en)
Other versions
DE69626680T2 (de
Inventor
L Hudkins
W Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26678542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69626680(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of DE69626680D1 publication Critical patent/DE69626680D1/de
Application granted granted Critical
Publication of DE69626680T2 publication Critical patent/DE69626680T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69626680T 1995-12-11 1996-12-11 Kondensierte isoindolone als proteinkinase c inhibitoren Expired - Fee Related DE69626680T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US873395P 1995-12-11 1995-12-11
US08/761,951 US5808060A (en) 1995-12-11 1996-12-09 Fused isoindolones
PCT/US1996/019853 WO1997021677A1 (en) 1995-12-11 1996-12-11 Fused isoindolones as inhibitors of protein kinase c

Publications (2)

Publication Number Publication Date
DE69626680D1 true DE69626680D1 (de) 2003-04-17
DE69626680T2 DE69626680T2 (de) 2003-11-06

Family

ID=26678542

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626680T Expired - Fee Related DE69626680T2 (de) 1995-12-11 1996-12-11 Kondensierte isoindolone als proteinkinase c inhibitoren

Country Status (15)

Country Link
US (1) US5808060A (de)
EP (1) EP0871612B1 (de)
KR (1) KR100534528B1 (de)
CN (1) CN1139573C (de)
AT (1) ATE234284T1 (de)
AU (1) AU701412B2 (de)
BR (1) BR9611947A (de)
CA (1) CA2239282C (de)
DE (1) DE69626680T2 (de)
DK (1) DK0871612T3 (de)
ES (1) ES2195033T3 (de)
HK (1) HK1016599A1 (de)
NZ (1) NZ325073A (de)
PT (1) PT871612E (de)
WO (1) WO1997021677A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6841567B1 (en) * 1999-02-12 2005-01-11 Cephalon, Inc. Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6399780B1 (en) 1999-08-20 2002-06-04 Cephalon, Inc. Isomeric fused pyrrolocarbazoles and isoindolones
US6630500B2 (en) 2000-08-25 2003-10-07 Cephalon, Inc. Selected fused pyrrolocarbazoles
US20040098106A1 (en) * 2002-11-14 2004-05-20 Williams Michael S. Intraluminal prostheses and carbon dioxide-assisted methods of impregnating same with pharmacological agents
US7285287B2 (en) * 2002-11-14 2007-10-23 Synecor, Llc Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses
US6932930B2 (en) * 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
US20070161648A1 (en) * 2005-10-14 2007-07-12 Hughes Terry V Substituted dihydro-isoindolones useful in treating kinase disorders
US20080021013A1 (en) * 2006-07-21 2008-01-24 Cephalon, Inc. JAK inhibitors for treatment of myeloproliferative disorders
CN103242404A (zh) * 2012-02-03 2013-08-14 复旦大学 N-鼠李糖基苯并咔唑化合物及其合成方法和在制药中的用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US4735939A (en) * 1987-02-27 1988-04-05 The Dow Chemical Company Insecticidal activity of staurosporine
EP0303697B1 (de) * 1987-03-09 1997-10-01 Kyowa Hakko Kogyo Co., Ltd. Derivate des physiologisch aktiven mittels k-252
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP3010675B2 (ja) * 1989-03-23 2000-02-21 萬有製薬株式会社 抗腫瘍性物質ｂｅ―１３７９３ｃ
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5489608A (en) * 1989-12-21 1996-02-06 Goedecke Aktiengesellschaft Indolocarbazole derivatives and the use thereof
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US6271242B1 (en) * 1992-02-10 2001-08-07 Bristol-Myers Squibb Co. Method for treating cancer using a tyrosine protein kinase inhibitor
JPH07504674A (ja) * 1992-03-20 1995-05-25 ザ・ウエルカム・ファウンデーション・リミテッド 抗ウイルス活性を有する更なるインドール誘導体
DE4217963A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Verwendung von Indolocarbazolen zur Behandlung von AIDS
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
EP0699204B1 (de) * 1993-05-28 1998-04-15 Cephalon, Inc. Anwendung von indolocarbazol-derivaten zur behandlung von prostataerkrankungen
US5468872A (en) * 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles

Also Published As

Publication number Publication date
HK1016599A1 (en) 1999-11-05
EP0871612A1 (de) 1998-10-21
AU1289397A (en) 1997-07-03
ES2195033T3 (es) 2003-12-01
CA2239282C (en) 2009-08-18
CN1139573C (zh) 2004-02-25
NZ325073A (en) 1999-04-29
DK0871612T3 (da) 2003-07-14
DE69626680T2 (de) 2003-11-06
AU701412B2 (en) 1999-01-28
CN1224417A (zh) 1999-07-28
ATE234284T1 (de) 2003-03-15
EP0871612B1 (de) 2003-03-12
BR9611947A (pt) 1999-04-06
KR19990072091A (ko) 1999-09-27
MX9804706A (es) 1998-10-31
PT871612E (pt) 2003-06-30
US5808060A (en) 1998-09-15
WO1997021677A1 (en) 1997-06-19
KR100534528B1 (ko) 2006-05-29
CA2239282A1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
NO308601B1 (no) Tricykliske benzazepiner og farmasøytisk preparat inneholdende disse
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
DE69413542T2 (de) Perhydroisoindolderivate als substanz p antagonisten
TR200201063T2 (tr) Bağışıklığı düzenleyici bir madde olan BAFF reseptörü (BCMA)
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
EA199700280A1 (ru) Ингибиторы протеинкиназы с
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
LU91320I2 (fr) "Ranibizumab et ses dérivés pharmaceutiquement acceptables (LUCENTIS )"
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
IS6266A (is) Ísómerísk sambrædd pýrrólókarbazól og ísóindólón
DE69919700D1 (de) Überbrückte indenopyrrolocarbazole
ATE234284T1 (de) Kondensierte isoindolone als proteinkinase c inhibitoren
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
EA200200732A1 (ru) Замещенные производные фенилпиперазина, их получение и применение
DE69524103T2 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
DE69610628D1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
NO930205L (no) Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
EA200200727A1 (ru) Новые производные индола
EA200100299A1 (ru) Уреидопиперидиновые производные как селективные антагонисты nk3 - рецепторов человека
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee